IMNM
Price
$9.56
Change
+$0.36 (+3.91%)
Updated
Jun 16, 04:59 PM (EDT)
Capitalization
830.1M
57 days until earnings call
LTRN
Price
$3.23
Change
+$0.17 (+5.57%)
Updated
Jun 16, 04:59 PM (EDT)
Capitalization
34.51M
50 days until earnings call
Interact to see
Advertisement

IMNM vs LTRN

Header iconIMNM vs LTRN Comparison
Open Charts IMNM vs LTRNBanner chart's image
Immunome
Price$9.56
Change+$0.36 (+3.91%)
Volume$35.24K
Capitalization830.1M
Lantern Pharma
Price$3.23
Change+$0.17 (+5.57%)
Volume$6K
Capitalization34.51M
IMNM vs LTRN Comparison Chart
Loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMNM vs. LTRN commentary
Jun 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a StrongBuy and LTRN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 17, 2025
Stock price -- (IMNM: $9.54 vs. LTRN: $3.20)
Brand notoriety: IMNM and LTRN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 114% vs. LTRN: 189%
Market capitalization -- IMNM: $830.1M vs. LTRN: $34.51M
IMNM [@Biotechnology] is valued at $830.1M. LTRN’s [@Biotechnology] market capitalization is $34.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $342.74B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileLTRN’s FA Score has 1 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • LTRN’s FA Score: 1 green, 4 red.
According to our system of comparison, IMNM is a better buy in the long-term than LTRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 5 TA indicator(s) are bullish while LTRN’s TA Score has 3 bullish TA indicator(s).

  • IMNM’s TA Score: 5 bullish, 2 bearish.
  • LTRN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, IMNM is a better buy in the short-term than LTRN.

Price Growth

IMNM (@Biotechnology) experienced а +2.91% price change this week, while LTRN (@Biotechnology) price change was -5.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.54%. For the same industry, the average monthly price growth was +9.93%, and the average quarterly price growth was +7.83%.

Reported Earning Dates

IMNM is expected to report earnings on Aug 13, 2025.

LTRN is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (-2.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($830M) has a higher market cap than LTRN($34.5M). LTRN YTD gains are higher at: -4.389 vs. IMNM (-13.371). LTRN has higher annual earnings (EBITDA): -21.24M vs. IMNM (-175.18M). IMNM has more cash in the bank: 317M vs. LTRN (19.7M). LTRN has less debt than IMNM: LTRN (195K) vs IMNM (4.77M). IMNM has higher revenues than LTRN: IMNM (10.9M) vs LTRN (0).
IMNMLTRNIMNM / LTRN
Capitalization830M34.5M2,406%
EBITDA-175.18M-21.24M825%
Gain YTD-13.371-4.389305%
P/E RatioN/AN/A-
Revenue10.9M0-
Total Cash317M19.7M1,609%
Total Debt4.77M195K2,446%
TECHNICAL ANALYSIS
Technical Analysis
IMNMLTRN
RSI
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 7 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
84%
MACD
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
N/A
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRUP50.830.23
+0.45%
Trupanion
O57.64-0.32
-0.55%
Realty Income Corp
SGRP1.06-0.02
-1.85%
SPAR Group
BIPC41.04-0.80
-1.91%
Brookfield Infrastructure Corp
DMRC12.52-0.75
-5.65%
Digimarc Corp

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-6.03%
IDYA - IMNM
60%
Loosely correlated
-0.45%
BEAM - IMNM
55%
Loosely correlated
-2.18%
ARWR - IMNM
55%
Loosely correlated
-2.96%
RXRX - IMNM
54%
Loosely correlated
-4.84%
SYRE - IMNM
54%
Loosely correlated
-2.37%
More

LTRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LTRN has been loosely correlated with IMNM. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if LTRN jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LTRN
1D Price
Change %
LTRN100%
-5.57%
IMNM - LTRN
34%
Loosely correlated
-6.03%
ABSI - LTRN
34%
Loosely correlated
-2.11%
MNMD - LTRN
34%
Loosely correlated
-1.78%
ATAI - LTRN
33%
Loosely correlated
-3.21%
SYRE - LTRN
33%
Loosely correlated
-2.37%
More